Soriano V, Concheiro Carro L, Gutiérrez M, Tuset C, Martínez-Zapico R, Ortiz de Lejarazu R, González A, Aguilera A, Codina G, Ulloa F
Servicio de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid.
Med Clin (Barc). 1993 Apr 17;100(15):561-6.
The Western blot (WB) is the most commonly used test to confirm the presence of antibodies against the human immunodeficiency virus type 1 (HIV-1). Different criteria of interpretation of the band profile have been proposed with there being no unanimity as to its reliability. The sensitivity and specificity of several criteria proposed for the interpretation of WB were evaluated and the individual significance of the reactivity of each band of the WB was analyzed.
The presence of antibodies against HIV-1 was prospectively studied in 8,073 samples of subjects with risk of infection. A total of 1,993 (25%) were reactive by ELISA and 1,261 were analyzed by WB, with a semiquantitative reading of the bands with a point scale from 0 to 2 being performed. The final interpretation of the WB (negative, doubtful, or positive) was carried out following 5 recommendations of usage. A test designed with synthetic peptides (Pepti-lav) was used as a reference and in discordant cases, other more specific serologic tests and/or genetic analysis by polymerase chain reaction (PCR) were performed.
In order of frequency, the greater sensitivity was found to be for the CRSS (Consortium for Retrovirus Serology Standardization) criteria (97.9%), OMS (96.6%), CDC (Center for Disease Control) (95.9%), ARC (American Red Cross) (95.6%) and FDA (99.8%). The greatest specificity was for the criteria of the OMS, and FDA (99.8%). In order of frequency, the most frequent bands in HIV-1 + individuals were gp160 (99%), gp120, p24, p31, p55, p68, gp41, and p17 (68%). In non infected individuals, the recognized bands were, in decreasing order, p24, p17, p55, p68, p31, and glucoproteins.
Different criteria of interpretation of the Western blot provide different degrees of sensitivity and specificity. The Western blot is a non standardized, expensive, laborious technique of subjective interpretation which provides an appreciable number of undetermined results.
蛋白质印迹法(WB)是用于确认抗1型人类免疫缺陷病毒(HIV-1)抗体存在的最常用检测方法。对于条带图谱的解读提出了不同标准,但对于其可靠性尚未达成一致意见。评估了为WB解读提出的几种标准的敏感性和特异性,并分析了WB每条带反应性的个体意义。
对8073份有感染风险受试者的样本进行前瞻性研究,检测抗HIV-1抗体的存在情况。共有1993份样本(25%)ELISA检测呈反应性,其中1261份进行了WB检测,采用0至2分的点量表对条带进行半定量读数。根据5项使用建议对WB进行最终解读(阴性、可疑或阳性)。使用合成肽设计的检测方法(Pepti-lav)作为参考,在结果不一致的情况下,进行其他更特异的血清学检测和/或聚合酶链反应(PCR)基因分析。
按频率排序,发现CRSS(逆转录病毒血清学标准化联盟)标准的敏感性最高(97.9%),其次是世界卫生组织(OMS)(96.6%)、美国疾病控制中心(CDC)(95.9%)、美国红十字会(ARC)(95.6%)和美国食品药品监督管理局(FDA)(99.8%)。特异性最高的是OMS和FDA的标准(99.8%)。按频率排序,HIV-1阳性个体中最常见的条带依次为gp160(99%)、gp120、p24、p31、p55、p68、gp41和p17(68%)。在未感染个体中,识别出的条带按频率从高到低依次为p24、p17、p55、p68、p31和糖蛋白。
蛋白质印迹法的不同解读标准提供了不同程度的敏感性和特异性。蛋白质印迹法是一种非标准化、昂贵、费力且主观解读的技术,会产生相当数量的不确定结果。